ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals Inc (1REGN)

718.60
19.00
( 2.72% )
Updated: 11:01:18

Regeneron Pharmaceuticals Inc Financial Summary

The current 1REGN market cap is 78.97B. The company's latest EPS is USD 35.9779 and P/E is 20.88.

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 7.86B8.78B16.12B12.26B13.12B
Operating Income 2.21B3.58B8.95B4.74B4.05B
Net Income 2.12B3.51B8.08B4.34B3.95B
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 14.81B17.16B25.43B29.21B33.08B
Total Liabilities 3.72B6.14B6.67B6.55B7.11B
Total Equity 11.09B11.03B18.77B22.66B25.97B

Cash Flow

Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating 2.43B2.62B7.08B5.01B4.59B
Investing -2.03B-70.6M-5.38B-3.78B-3.19B
Financing -252.1M-1.97B-1.01B-1.01B-1.79B
Market Cap 78.97B
Price to Earnings Ratio 20.88
Price to Sales Ratio 6.29
Price to Cash Ratio 30.24
Price to Book Ratio 3.18
Dividend Yield -

Share Statistics

Shares Outstanding 109.89M
Average Volume (1 week) 15
Average Volume (1 Month) 20
52 Week Change -1.56%
52 Week High 1,094.50
52 Week Low 699.60
Spread (Intraday) 4.4 (0.61%)

Company Info

Company Name Regeneron Pharmaceuticals Inc
Address 28 liberty street
new york, new york 10005
Website https://www.regeneron.com
Industry health care diversified (H)

Your Recent History

Delayed Upgrade Clock